CBDS Stock Overview
Through its subsidiaries, primarily provides telemedicine online referral services for customers desiring medical marijuana cards in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
My Notes
Capture your thoughts, links and company narrative
Dogecoin Cash, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.11 |
| 52 Week High | US$0.17 |
| 52 Week Low | US$0.0028 |
| Beta | 2.4 |
| 1 Month Change | 1,410.34% |
| 3 Month Change | 1,821.05% |
| 1 Year Change | 1,855.36% |
| 3 Year Change | -50.23% |
| 5 Year Change | -77.19% |
| Change since IPO | -84.58% |
Recent News & Updates
Recent updates
Shareholder Returns
| CBDS | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 46.2% | -4.5% | -0.9% |
| 1Y | 1,855.4% | -6.4% | 27.6% |
Return vs Industry: CBDS exceeded the US Healthcare industry which returned -6.4% over the past year.
Return vs Market: CBDS exceeded the US Market which returned 27.6% over the past year.
Price Volatility
| CBDS volatility | |
|---|---|
| CBDS Average Weekly Movement | 61.8% |
| Healthcare Industry Average Movement | 7.0% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: CBDS's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: CBDS's weekly volatility has increased from 41% to 61% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 7 | David Tobias | n/a |
Dogecoin Cash, Inc., through its subsidiaries, primarily provides telemedicine online referral services for customers desiring medical marijuana cards in the United States. The company offers PrestoDoctor, an online telemedicine platform, which provides access to physicians for getting a medical marijuana recommendation using video conferencing technology. Its products under development include Lozenges for relief from throat irritation; Recover, a deep penetrating healing balm used to relieve pain for sore muscles, joints, arthritic, and back pain; Trauma Cream, a cream for blended infusion of cannabinoids and THC; Face Garden, an antioxidant moisturizing cream for the face; Body Garden, a moisturizing body lotion; and Lip Garden, an emollient balm.
Dogecoin Cash, Inc. Fundamentals Summary
| CBDS fundamental statistics | |
|---|---|
| Market cap | US$11.42m |
| Earnings (TTM) | -US$1.11m |
| Revenue (TTM) | US$964.79k |
13.0x
P/S Ratio-11.2x
P/E RatioIs CBDS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CBDS income statement (TTM) | |
|---|---|
| Revenue | US$964.79k |
| Cost of Revenue | US$357.86k |
| Gross Profit | US$606.93k |
| Other Expenses | US$1.72m |
| Earnings | -US$1.11m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0097 |
| Gross Margin | 62.91% |
| Net Profit Margin | -115.35% |
| Debt/Equity Ratio | 203.2% |
How did CBDS perform over the long term?
See historical performance and comparison